NO20054006D0 - Cyclic urea derivatives, their preparation process and the pharmaceutical use of the same as kinase inhibitors - Google Patents
Cyclic urea derivatives, their preparation process and the pharmaceutical use of the same as kinase inhibitorsInfo
- Publication number
- NO20054006D0 NO20054006D0 NO20054006A NO20054006A NO20054006D0 NO 20054006 D0 NO20054006 D0 NO 20054006D0 NO 20054006 A NO20054006 A NO 20054006A NO 20054006 A NO20054006 A NO 20054006A NO 20054006 D0 NO20054006 D0 NO 20054006D0
- Authority
- NO
- Norway
- Prior art keywords
- same
- preparation process
- kinase inhibitors
- pharmaceutical use
- urea derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Obesity (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0301098A FR2850652B1 (en) | 2003-01-31 | 2003-01-31 | NOVEL CYCLIC UREA DERIVATIVES, THEIR PREPARATION AND THEIR PHARMACEUTICAL USE AS INHIBITORS OF KINASES |
PCT/FR2004/000188 WO2004070050A2 (en) | 2003-01-31 | 2004-01-28 | Cyclic urea derivatives, preparation method thereof and pharmaceutical use of same as kinase inhibitors |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20054006D0 true NO20054006D0 (en) | 2005-08-29 |
NO20054006L NO20054006L (en) | 2005-10-13 |
Family
ID=32696243
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20054006A NO20054006L (en) | 2003-01-31 | 2005-08-29 | Cyclic urea derivatives, their preparation process and the pharmaceutical use of the same as kinase inhibitors |
Country Status (24)
Country | Link |
---|---|
EP (1) | EP1599464B1 (en) |
JP (1) | JP4604020B2 (en) |
KR (1) | KR20050098286A (en) |
CN (1) | CN1768054A (en) |
AR (1) | AR042936A1 (en) |
AT (1) | ATE482207T1 (en) |
AU (1) | AU2004209319A1 (en) |
BR (1) | BRPI0407091A (en) |
CA (1) | CA2513631A1 (en) |
DE (1) | DE602004029236D1 (en) |
FR (1) | FR2850652B1 (en) |
HR (1) | HRP20050679A2 (en) |
MA (1) | MA27651A1 (en) |
ME (1) | MEP22608A (en) |
MX (1) | MXPA05007407A (en) |
NO (1) | NO20054006L (en) |
NZ (1) | NZ541270A (en) |
PE (1) | PE20040808A1 (en) |
PL (1) | PL377811A1 (en) |
RS (1) | RS20050657A (en) |
RU (1) | RU2341523C2 (en) |
TW (1) | TW200505898A (en) |
WO (1) | WO2004070050A2 (en) |
ZA (1) | ZA200505934B (en) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK2384753T3 (en) * | 2003-08-29 | 2016-04-11 | Brigham & Womens Hospital | Hydantoin derivatives as inhibitors of cell necrosis |
US7700603B2 (en) | 2003-12-15 | 2010-04-20 | Schering Corporation | Heterocyclic aspartyl protease inhibitors |
US7763609B2 (en) | 2003-12-15 | 2010-07-27 | Schering Corporation | Heterocyclic aspartyl protease inhibitors |
US7592348B2 (en) | 2003-12-15 | 2009-09-22 | Schering Corporation | Heterocyclic aspartyl protease inhibitors |
ATE502298T1 (en) | 2003-12-19 | 2011-04-15 | Univ California | METHODS AND MATERIALS FOR ASSESSING PROSTATE CANCER THERAPIES |
NZ550102A (en) | 2004-02-24 | 2010-10-29 | Univ California | Methods and materials for assessing prostate cancer therapies and compounds (thiohydantoine derivatives) |
EP1621536A1 (en) * | 2004-07-27 | 2006-02-01 | Aventis Pharma S.A. | Amino cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors |
EP1621535A1 (en) * | 2004-07-27 | 2006-02-01 | Aventis Pharma S.A. | Substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors |
US7709517B2 (en) | 2005-05-13 | 2010-05-04 | The Regents Of The University Of California | Diarylhydantoin compounds |
EP3970721A1 (en) | 2005-05-13 | 2022-03-23 | The Regents Of The University Of California | Diarylhydantoin compounds as androgen receptor antagonists for treatment of cancer |
US7709516B2 (en) | 2005-06-17 | 2010-05-04 | Endorecherche, Inc. | Helix 12 directed non-steroidal antiandrogens |
FR2896504B1 (en) | 2006-01-23 | 2012-07-13 | Aventis Pharma Sa | NOVEL CYCLIC UREA DERIVATIVES, THEIR PREPARATION AND THEIR PHARMACEUTICAL USE AS INHIBITORS OF KINASES |
FR2896503B1 (en) * | 2006-01-23 | 2012-07-13 | Aventis Pharma Sa | NOVEL CYCLIC UREA SULFUR DERIVATIVES, THEIR PREPARATION AND THEIR PHARMACEUTICAL USE AS INHIBITORS OF KINASES |
EP2004181B3 (en) | 2006-03-27 | 2023-05-24 | The Regents Of The University Of California | Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases |
US8110594B2 (en) | 2006-03-29 | 2012-02-07 | The Regents Of The University Of California | Diarylthiohydantoin compounds |
WO2008017381A1 (en) | 2006-08-08 | 2008-02-14 | Sanofi-Aventis | Arylaminoaryl-alkyl-substituted imidazolidine-2,4-diones, processes for preparing them, medicaments comprising these compounds, and their use |
KR20090087487A (en) | 2006-12-12 | 2009-08-17 | 쉐링 코포레이션 | Aspartyl protease inhibitors |
CA2966280A1 (en) | 2007-10-26 | 2009-04-30 | The Regents Of The University Of California | Diarylhydantoin compounds |
CN104803986A (en) | 2008-12-23 | 2015-07-29 | 哈佛大学校长及研究员协会 | Small molecule inhibitors of necroptosis |
CN106983749A (en) | 2010-02-16 | 2017-07-28 | 亚拉冈制药公司 | Androgen receptor modifier and application thereof |
EA028199B1 (en) * | 2010-12-21 | 2017-10-31 | Сайтек Текнолоджи Корп. | Microdispersions of hydroxamated polymers and methods of making and using them |
US8492556B2 (en) * | 2011-11-10 | 2013-07-23 | Allergan, Inc. | 2,5-Dioxoimidazolidin-1-yl-3-phenylurea derivatives as formyl peptide receptor like-1 (FPRL-1) receptor modulators |
ES2836424T3 (en) | 2012-09-26 | 2021-06-25 | Aragon Pharmaceuticals Inc | Antiandrogens to treat castration-resistant and non-metastatic prostate cancer |
JOP20200097A1 (en) | 2013-01-15 | 2017-06-16 | Aragon Pharmaceuticals Inc | Androgen receptor modulator and uses thereof |
WO2014145022A1 (en) | 2013-03-15 | 2014-09-18 | President And Fellows Of Harvard College | Hybrid necroptosis inhibitors |
GB201312492D0 (en) * | 2013-07-12 | 2013-08-28 | Syngenta Ltd | Herbicidal compounds |
EP3094326A4 (en) | 2014-01-14 | 2017-07-26 | Millennium Pharmaceuticals, Inc. | Heteroaryls and uses thereof |
TN2016000270A1 (en) | 2014-01-14 | 2017-10-06 | Millennium Pharm Inc | Heteroaryls and uses thereof. |
EP3229807A4 (en) | 2014-12-11 | 2018-10-17 | President and Fellows of Harvard College | Inhibitors of cellular necrosis and related methods |
TWI726969B (en) | 2016-01-11 | 2021-05-11 | 比利時商健生藥品公司 | Substituted thiohydantoin derivatives as androgen receptor antagonists |
CN107619388A (en) * | 2016-07-13 | 2018-01-23 | 南京天印健华医药科技有限公司 | Heterocyclic compound as FGFR inhibitor |
TWI755255B (en) * | 2016-07-20 | 2022-02-11 | 瑞士商諾華公司 | Aminopyridine derivatives and their use as selective alk-2 inhibitors |
JOP20200076A1 (en) | 2017-10-16 | 2020-04-30 | Aragon Pharmaceuticals Inc | Anti-androgens for the treatment of non-metastatic castration-resistant prostate cancer |
EP3705474A4 (en) * | 2017-10-31 | 2021-06-09 | Pelemed Co., Ltd. | Pharmaceutical composition for prevention or treatment of acute myeloid leukemia or metastatic breast cancer |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2329276A1 (en) * | 1975-10-29 | 1977-05-27 | Roussel Uclaf | NEW SUBSTITUTES IMIDAZOLIDINES, METHOD OF PREPARATION, APPLICATION AS A MEDICINAL PRODUCT AND COMPOSITIONS CONTAINING THEM |
DE4228717A1 (en) * | 1992-08-28 | 1994-03-03 | Cassella Ag | Imidazolidine derivatives |
DE19540027A1 (en) * | 1995-10-27 | 1997-04-30 | Gruenenthal Gmbh | Substituted imidazolidine-2,4-dione compounds as active pharmaceutical ingredients |
TR199902124T2 (en) * | 1997-03-03 | 2000-06-21 | Boehringer Ingelheim Pharmaceuticals, Inc. | Small molecules useful in the treatment of inflammatory diseases. |
DE19732928C2 (en) * | 1997-07-31 | 2000-05-18 | Gruenenthal Gmbh | Use of substituted imidazolidine-2,4-dione compounds as pain relievers |
FR2796945B1 (en) * | 1999-07-30 | 2002-06-28 | Sod Conseils Rech Applic | NOVEL DERIVATIVES OF HYDANTOINS, THIOHYDANTOINS, PYRIMIDINEDIONES AND THIOXOPYRIMIDINONES, PROCESSES FOR THEIR PREPARATION AND THEIR APPLICATION AS MEDICAMENTS |
CN1209358C (en) * | 2000-05-31 | 2005-07-06 | 田边制药株式会社 | Inhibitors of alpha L beta 2 mediated cell adhesion |
US7476685B2 (en) * | 2002-05-16 | 2009-01-13 | Merial Limited | Pyridine carboxamide derivatives and their use as pesticides |
-
2003
- 2003-01-31 FR FR0301098A patent/FR2850652B1/en not_active Expired - Fee Related
-
2004
- 2004-01-22 PE PE2004000090A patent/PE20040808A1/en not_active Application Discontinuation
- 2004-01-27 AR ARP040100233A patent/AR042936A1/en unknown
- 2004-01-28 RS YUP-2005/0657A patent/RS20050657A/en unknown
- 2004-01-28 MX MXPA05007407A patent/MXPA05007407A/en active IP Right Grant
- 2004-01-28 AT AT04705838T patent/ATE482207T1/en not_active IP Right Cessation
- 2004-01-28 KR KR1020057014096A patent/KR20050098286A/en not_active Application Discontinuation
- 2004-01-28 BR BR0407091-7A patent/BRPI0407091A/en not_active IP Right Cessation
- 2004-01-28 ME MEP-226/08A patent/MEP22608A/en unknown
- 2004-01-28 EP EP04705838A patent/EP1599464B1/en not_active Expired - Lifetime
- 2004-01-28 DE DE602004029236T patent/DE602004029236D1/en not_active Expired - Lifetime
- 2004-01-28 PL PL377811A patent/PL377811A1/en not_active Application Discontinuation
- 2004-01-28 JP JP2006502123A patent/JP4604020B2/en not_active Expired - Fee Related
- 2004-01-28 WO PCT/FR2004/000188 patent/WO2004070050A2/en active Application Filing
- 2004-01-28 NZ NZ541270A patent/NZ541270A/en unknown
- 2004-01-28 CN CNA2004800088356A patent/CN1768054A/en active Pending
- 2004-01-28 AU AU2004209319A patent/AU2004209319A1/en not_active Abandoned
- 2004-01-28 CA CA002513631A patent/CA2513631A1/en not_active Abandoned
- 2004-01-28 RU RU2005127335/04A patent/RU2341523C2/en not_active IP Right Cessation
- 2004-01-30 TW TW093102064A patent/TW200505898A/en unknown
-
2005
- 2005-07-22 ZA ZA200505934A patent/ZA200505934B/en unknown
- 2005-07-29 MA MA28417A patent/MA27651A1/en unknown
- 2005-07-29 HR HR20050679A patent/HRP20050679A2/en not_active Application Discontinuation
- 2005-08-29 NO NO20054006A patent/NO20054006L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JP2006517569A (en) | 2006-07-27 |
MXPA05007407A (en) | 2005-09-12 |
PL377811A1 (en) | 2006-02-20 |
ZA200505934B (en) | 2007-06-27 |
AU2004209319A1 (en) | 2004-08-19 |
HRP20050679A2 (en) | 2006-12-31 |
JP4604020B2 (en) | 2010-12-22 |
WO2004070050A2 (en) | 2004-08-19 |
NO20054006L (en) | 2005-10-13 |
CA2513631A1 (en) | 2004-08-19 |
RU2341523C2 (en) | 2008-12-20 |
KR20050098286A (en) | 2005-10-11 |
DE602004029236D1 (en) | 2010-11-04 |
EP1599464A2 (en) | 2005-11-30 |
CN1768054A (en) | 2006-05-03 |
FR2850652A1 (en) | 2004-08-06 |
FR2850652B1 (en) | 2008-05-30 |
WO2004070050A3 (en) | 2005-02-17 |
RS20050657A (en) | 2007-06-04 |
NZ541270A (en) | 2008-11-28 |
PE20040808A1 (en) | 2004-12-31 |
MA27651A1 (en) | 2005-12-01 |
AR042936A1 (en) | 2005-07-06 |
ATE482207T1 (en) | 2010-10-15 |
RU2005127335A (en) | 2006-09-10 |
TW200505898A (en) | 2005-02-16 |
EP1599464B1 (en) | 2010-09-22 |
BRPI0407091A (en) | 2006-01-24 |
MEP22608A (en) | 2010-06-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20054006D0 (en) | Cyclic urea derivatives, their preparation process and the pharmaceutical use of the same as kinase inhibitors | |
IL180488A0 (en) | Substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof of kinase inhibitors | |
IL180286A0 (en) | Novel cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors | |
ZA200700706B (en) | Heterocycle-substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors | |
NO20054905D0 (en) | 2-acylamino-4-phenylthiazole derivatives, processes for their preparation and use of the same as in therapeutics | |
NO20053356L (en) | Aminindazole derivatives and their use as kinase inhibitors. | |
NO20034187D0 (en) | Novel spirotric cyclic derivatives and their use as phosphodiesterase-7 inhibitors | |
IS7543A (en) | Benzothiadiazepine derivatives, methods of their manufacture and pharmaceutical compositions containing them | |
DK1523488T3 (en) | Novel Thiophenglycoside Derivatives, Methods for their Preparation, Drugs Containing These Compounds and Their Use | |
AP2064A (en) | Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors | |
DK1368349T3 (en) | Xanthine derivatives, their preparation and their use as pharmaceuticals | |
NO20055204D0 (en) | Derivatives of piperidinyl and pipemzinylalkylcarbamates, processes for their preparation and their use in therapy | |
NO20054244D0 (en) | Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient | |
NO20054876D0 (en) | Substituted 4-phenyltetrahydroisoquinolines, process for their preparation, their use as drug and drug containing such compounds | |
EE200300581A (en) | Carboxamide-substituted phenylurea derivatives and their use, drug and process for its preparation | |
EE200300327A (en) | Urea derivatives, processes for their preparation, use and pharmaceutical composition | |
IL192440A0 (en) | Sulphur-containing cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors | |
DK1670458T3 (en) | 1-Amino-2-oxy-substituted tetrahydronaphthalane derivatives, processes for their preparation and their use as antiphlogistics | |
IL192442A0 (en) | Novel cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors | |
DK1500654T3 (en) | Benzoxazinone derivatives, their preparation and their use as pharmaceuticals | |
IL182054A0 (en) | Novel bis-azaindole derivatives, preparation and pharmaceutical use thereof as kinase inhibitors | |
NO20053588L (en) | Acylaminothiazole derivatives, their preparation and use as beta-amyloid peptide production inhibitors. | |
IS8164A (en) | Cyclic amine derivatives, methods of producing them and pharmaceutical compositions containing them | |
IS7424A (en) | Oxazolidinone derivatives, methods of preparing them and pharmaceutical compositions containing them | |
NO20053805D0 (en) | Diarylmethylindenepiperidine derivatives, processes for their preparation, and use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |